INDICAL − Improving diagnostics for better animal and human health With three decades of experience, INDICAL (formerly QIAGEN's veterinary business) is a leading provider of molecular diagnostic workflows, the protocols for their use and support that empowers our customers every day. Our customers play a central role in protecting the health of animals and humans. INDICAL’s sample prep kits, assays, reagents and instruments are used by veterinarians, industry and government agencies worldwide. Today, INDICAL is an independent company with renewed focus and ambition to pursue our mission with even greater impact – improving diagnostics for better animal and human health.
| Website | http://www.indical.com |
| Revenue | $17.3 million |
| Employees | 72 (56 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+24 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Molecular Diagnostics, Veterinary Diagnostics, Animal Health Diagnostics, Molecular Testing, Diagnostic Assays, Precision Diagnostics, In Vitro Diagnostics, Diagnostic Reagents, Animal Healthcare, Diagnostic Support, Clinical Diagnostics, Diagnostic Equipment, Human Healthcare, Life Sciences, Medical Technology, Biotechnology, Health Technology |
| Competitors | Thermo Fisher Scientific, Merck Animal Health, Boehringer Ingelheim, IDEXX, Elanco, QIAGEN, Neogen Corporation, Genzyme Europe B.V., Heska, Biovet JSCo +24 more (view full list) |
Looking for a particular INDICAL BIOSCIENCE employee's phone or email?
The INDICAL BIOSCIENCE annual revenue was $17.3 million in 2026.
Stefano Santarelli is the CEO of INDICAL BIOSCIENCE.
56 people are employed at INDICAL BIOSCIENCE.